Best Startup
At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United Kingdom based VP’ operating in the Health Diagnostics space. If you think a VP’ is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Roger Pettett
VP, Informatics of Oxford Nanopore Technologies
Follow Roger Pettett:
About Oxford Nanopore Technologies: Oxford Nanopore Technologies develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins.
Tim Cowper
VP, Finance of Oxford Nanopore Technologies
Tim Cowper is a Chartered Accountant and Operations specialist who has worked across a range of life science/healthcare companies in the UK and US, both private and public companies. These include Celltech, Vernalis/British Biotech, Bioventix and Sterilox. Qualified as an Accountant at Ernst & Young (Ernst & Whinney), Tim has directed companies in their financial management and also through transactions including M&A, reorganisations and IPOs. Tim joined Oxford Nanopore in a financial and operations role in 2012 and oversees the financial team as well as strategic supply chain operations. Tim is a keen sailor and was also Finance Director of Clipper Ventures.
Follow Tim Cowper:
About Oxford Nanopore Technologies: Oxford Nanopore Technologies develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins.
Zeshan Ghory
VP of Operations & Analytics of Antidote.me
Follow Zeshan Ghory:
About Antidote.me: Antidote is a digital health company that accelerates and improves medical research by combining technologies, data, and business models.
Gareth Ridge
Senior Vice President of Operations & Site Head of Cambridge Epigenetix
Gareth has a degree in Pharmacology from the University of Cambridge and has worked in the pharmaceutical sector for over 20 years. During his career he has worked for both large and small pharma, biotechnology and clinical research organisations, he also has five years’ experience in business consultancy. In addition to delivering successful clinical research projects Gareth has managed business change projects – including system implementations, process reengineering and organisational change. He has held many leadership positions with responsibility for project and revenue delivery and strategic growth and has had oversight of over 70 clinical research studies, either directly as project manager or as responsible head, and has worked in high growth companies where he successfully built a team to successfully deliver 700% growth in project delivery & revenue in 2 years.
Follow Gareth Ridge:
About Cambridge Epigenetix: Cambridge Epigenetix is using epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw.
Joanna Holbrook
Senior Vice President of Research of Cambridge Epigenetix
Joanna started her career in GSK R&D, working for seven years in the UK bioinformatics department, processing the integrating ‘omic data for drug target identification and validation mostly focussing on neurological disease, and then for three years in GSK USA Oncology R&D working on biomarkers for targeted therapies. She then left GSK and the USA for Singapore and built an academic group in A*STAR Singapore Institute for Clinical Sciences. Her group focused on epigenomic trackers of complex disease, especially the interaction of genetic, environmental and disease states in shaping the human epigenome. Her work in Singapore encompassed set-up of observational and interventional cohorts, biobanking, clinical databases, production, processing and analysis of biosample ‘omic profiles and multiple industrial collaborations. Moving back to the UK five years later, she took up a professorship at the University of Southampton, still working on epigenomics and also integration of electronic health record data to clinical cohorts. Most recently she has been VP of Translational Medicine at BenevolentAI, a fast growing British Biotech, where she initiated and led integration of ‘omic data into a large biomedical knowledge graph and machine learning approaches to analyses of patient-level data for precision medicine.
Follow Joanna Holbrook:
About Cambridge Epigenetix: Cambridge Epigenetix is using epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw.
Giles Snare
Vice President , Sales Developed Markets of Beckman Coulter
Follow Giles Snare:
About Beckman Coulter: Beckman Coulter develops, manufactures and markets products that simplify & automate biomedical testing for lab professionals.
Clare Cooper
Founder and Vice President of Storm3
Clare Cooper is the Founder and Vice President at Storm3.
Follow Clare Cooper:
About Storm3: Storm3 are a global HealthTech talent marketplace, connecting organizations with the talent to drive their mission.
Daniel Barnett
MD Ireland and VP Primary Care Service Delivery UK of HealthHero
Follow Daniel Barnett:
About HealthHero: HealthHero offers remote access to experienced doctors and expert clinicians directly to patients, insurance-policy holders and employees.
